Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Prepaid Assets (2022 - 2026)

Sagimet Biosciences' Prepaid Assets history spans 5 years, with the latest figure at $248000.0 for Q1 2026.

  • Quarterly Prepaid Assets fell 10.47% to $248000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $248000.0 through Mar 2026, down 10.47% year-over-year, with the annual reading at $1.4 million for FY2025, 2806.25% up from the prior year.
  • Prepaid Assets came in at $248000.0 for Q1 2026, down from $1.4 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $1.7 million in Q4 2023 to a low of $48000.0 in Q4 2024.
  • The 5-year median for Prepaid Assets is $173000.0 (2025), against an average of $431692.3.
  • Year-over-year, Prepaid Assets crashed 97.26% in 2024 and then soared 2806.25% in 2025.
  • Sagimet Biosciences' Prepaid Assets stood at $61000.0 in 2022, then skyrocketed by 2767.21% to $1.7 million in 2023, then plummeted by 97.26% to $48000.0 in 2024, then skyrocketed by 2806.25% to $1.4 million in 2025, then tumbled by 82.22% to $248000.0 in 2026.
  • Per Business Quant, the three most recent readings for SGMT's Prepaid Assets are $248000.0 (Q1 2026), $1.4 million (Q4 2025), and $628000.0 (Q3 2025).